Results 241 to 250 of about 109,213 (308)

Engineering of the Flavone Rutinoside Biosynthetic Pathway Enables Production of Diosmin, a Venoactive Compound in Solanum lycopersicum and Nicotiana tabacum

Plant Biotechnology Journal, EarlyView.
ABSTRACT Diosmin is often used as a dietary supplement, and it is sometimes used to make phlebotropic drugs for venous diseases. Traditionally, diosmin is obtained by the dehydrogenation of the flavanone glycoside hesperidin through chemical semisynthesis.
Qianle Zhang, Qingwen Wu, Wenjing Shi, Yinai Deng, Ruoting Zhan, Dongming Ma   +5 more
wiley   +1 more source

RNA Therapeutics: Focus on Antisense Oligonucleotides in the Nervous System. [PDF]

Biomol Ther (Seoul)
Ertural B, Çiçek BN, Kurnaz IA.
europepmc   +1 more source

Application of Antisense Oligonucleotides as an Alternative Approach for Gene Expression Control and Functional Studies. [PDF]

Int J Mol Sci
Szukowska A, Żuk M, Sztompke J, Bednarz B, Kaźmierczak U.   +4 more
europepmc   +1 more source

A Cuproptosis-Related lncRNA Signature Predicts Prognosis and Shapes the Immune Landscape in Primary Lower-Grade Glioma. [PDF]

Genet Res (Camb)
Wang M, Yang J, Shen L, Yang J, Luo M, Duan F.   +5 more
europepmc   +1 more source

The influence of HIV sense and antisense transcripts on stochastic HIV transcription and reactivation. [PDF]

Comput Struct Biotechnol J
Więcek K, Wiśniewski J, Chen HC.
europepmc   +1 more source

Viral and non-viral cellular therapies for neurodegeneration. [PDF]

Front Med (Lausanne)
Srivastav J, Sharma S.
europepmc   +1 more source

lncRNAs: a new generation of targets and biomarkers in thyroid cancer. [PDF]

Eur Thyroid J
Maturi R, Esposito M, Coppes RP, De Vita G.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Nephrotoxicity of marketed antisense oligonucleotide drugs

Current Opinion in Toxicology, 2022
The field of antisense oligonucleotide (ASO)-based therapies have been making strides in precision medicine due to their potent therapeutic application. Early successes in treating some genetic diseases are now attributed to an emerging class of antisense drugs.
Hangyu Wu, Aniket Wahane, Feryal Alhamadani, Kristy Zhang, Rajvi Parikh, SooWan Lee, Evan M. McCabe, Theodore P. Rasmussen, Raman Bahal, Xiao-bo Zhong, José E. Manautou   +10 more
openaire   +2 more sources